AKM FINGOLIMOD, PHARMACOR FINGOLIMOD (Pharmacor Pty Ltd)
Product name
AKM FINGOLIMOD, PHARMACOR FINGOLIMOD
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
232 working days (255)
Active ingredients
fingolimod hydrochloride
Registration type
New generic medicine
Indication
AKM FINGOLIMOD, PHARMACOR FINGOLIMOD (capsule) is indicated for the treatment of Relapsing Remitting Multiple Sclerosis and Secondary Progressive Multiple Sclerosis with superimposed relapses to delay the progression of physical disability and reduce the frequency of relapse.